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A-kinase anchoring proteins (AKAPs) represent a family of
structurally diverse proteins, all of which bind PKA. A member
of this family is glycogen synthase kinase 3 (GSK3) interac-
tion protein (GSKIP). GSKIP interacts with PKA and also
directly interacts withGSK3. The physiological function of the
GSKIP protein in vivo is unknown. We developed and charac-
terized a conditional knock-out mouse model and found that
GSKIP deficiency caused lethality at birth. Embryos obtained
throughCaesarean section at embryonic day 18.5were cyanotic,
suffered from respiratory distress, and failed to initiate breath-
ing properly. Additionally, all GSKIP-deficient embryos showed
an incomplete closure of the palatal shelves accompanied by a
delay in ossification along the fusion area of secondary palatal
bones. On the molecular level, GSKIP deficiency resulted in
decreased phosphorylation of GSK3 at Ser-9 starting early in
development (embryonic day 10.5), leading to enhancedGSK3
activity. At embryonic day 18.5, GSK3 activity decreased to
levels close to that of wild type. Our findings reveal a novel,
crucial role forGSKIP in the coordinationofGSK3 signaling in
palatal shelf fusion.
PKA is a serine/threonine kinase that controls a wide variety
of cellular processes (1, 2). A-kinase anchoring proteins
(AKAPs)2 directly interact with the regulatory (R) subunits of
PKA and facilitate PKA phosphorylation of its substrates at
specific intracellular compartments (3–5). This coordinating
function of AKAPs is not limited to PKA signaling; AKAPs
directly bind further signaling proteins and thereby coordinate
crosstalk between multiple signaling pathways. An example is
the AKAP glycogen synthase kinase 3 (GSK3) interaction
protein (GSKIP). GSKIP directly interacts with PKA and
GSK3 (6), but its functions have not been determined.
Recently, an autosomal dominant 700-kb duplication encom-
passing theGskip genewas identified in humans; this alteration
causes a predisposition for myeloid malignancies, indicating a
likely role in tumorigenesis (7).
To date, functional analyses of the GSKIP protein have been
limited to in vitro and overexpression studies. GSKIP contains a
structurally conserved PKA-binding domain (amino acids
28–52) that is characteristic for AKAPs and specifically binds
regulatory RII subunits of PKA. GSK3 binds GSKIP at its
C-terminal conserved GSK3-binding domain (GID; amino
acids 115–139) (6, 8). The interaction between GSKIP and
GSK3 through the GID is conserved among vertebrates and
invertebrates, whereas its interaction with PKA RII subunits is
restricted to vertebrates. This indicates that it functions as an
AKAP exclusively in vertebrates (6).
GSK3 is a highly conserved serine-threonine kinase involved
in a plethora of cellular processes including glycogen metabo-
lism, proliferation, differentiation, and development. It is found
in the cytosol, nucleus, and mitochondria of all eukaryotic cells
(9). There are two homologous genes encoding two isoforms of
GSK3, GSK3 (51 kDa) and GSK3 (47 kDa). Both isoforms of
GSK3 are constitutively active and phosphorylate primed sub-
strates, i.e. substrates that have been pre-phosphorylated by
casein kinase 1 (CK1), MAPK, ERK, or other kinases (reviewed
in Ref. 10). Despite their structural similarities, GSK3 and
GSK3 are functionally non-redundant (11). GSK3 activity is
inhibited by Ser-9 phosphorylation (12). We have shown that
GSKIP facilitates the inhibitory phosphorylation of GSK3 at
Ser-9 by PKA when overexpressed in cultured cells (6).
GSK3 is a component of the canonical Wnt signaling path-
way, which plays a critical role in embryonic development.
Canonical Wnt signaling controls essential processes such as
body axis patterning, cell proliferation, epithelial cell fate, and
cell migration (13, 14). Studies of Wnt-related knock-out
mouse models revealed that the dysregulation of Lrp6 (15),
Gpr177 (16),Wnt5a (17), andWnt9b (18) induces palatal cleft-
ing, an abnormal development of facial structure (19).Wnt sig-
naling is activated by binding of Wnt ligands to receptor com-
plexes at the plasma membrane that consist of LRP5/6
transmembrane proteins and G protein-like receptors of the
Frizzled (Fz) family. The knock-out of Lrp6 resulted in defects
in orofacial development and disruptions of other embryonic
features. Lrp6/ animals exhibit hypoplasia of the upper lip
andmidline cleft of themandible at embryonic day 13.5 (E13.5),
and the absence of the primary palate at E16.5 (15), giving rise to
a cleft lip and palate phenotype. Gpr177 (mouse ortholog of
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Wntless) is a ubiquitous transmembrane protein directly acti-
vated by -catenin and TCF/LEF-dependent transcription.
Gpr177-Wnt complexes enhanceWnt production in a positive
feedback loop. Mice deficient for mesenchymal Gpr177 in
craniofacial neural crest cells display a secondary cleft palate,
which is mainly due to aberrant cell proliferation and increased
cell death in the palatal shelves (16). Wnt5a deficiency also
causes a secondary cleft palate. These mice exhibited altered
cell proliferation patterns and a lack of directional cell migra-
tion along the anterior-posterior axis within the developmental
palate (17). 50% ofWnt9b knock-outmice display a cleft lip and
palate (20), and inactivating mutations inWnt9 lead to a lethal
syndrome of fully penetrant vestigial kidneys and the lack of
reproductive ducts (21).
In canonical Wnt signaling, GSK3 assembles with Axin,
-catenin, adenomatous polyposis coli (APC), and CK1 in the
destruction complex located in the cytosol. In the absence of a
Wnt signal, GSK3 phosphorylates -catenin (22–26), thus
promoting its ubiquitination and proteasomal degradation.
Activation of Wnt signaling leads to the inhibition of GSK3
through phosphorylation, allowing -catenin to accumulate
and induce transcription of Wnt target genes. Inhibitors of
GSK3 includeGSKIP andGSKIPtide, a peptide encompassing
the GID and corresponding to amino acid residues 115–139 of
GSKIP; they activate the canonical Wnt signaling pathway in
neuroblastoma SH-SY5Y cells (27). The overexpression of
GSKIP induces-catenin accumulation in the cytoplasmand in
the nucleus and down-regulates N-cadherin expression, thus
blocking neurite outgrowth during retinoic acid-mediated dif-
ferentiation of the cells (8).
Despite considerable knowledge of GSKIP functions gained
in cell culture systems, its physiological relevance remains
unknown. Here we generated and characterized a new condi-
tionalGskip knock-out mouse to gain insights into its function.
GSKIP deficiency is associated with the modulation of GSK3
activity during development and a cleft palate.
Experimental Procedures
Mice—To generate conditionalGskipmice (Gskipfl/fl), exon 2
was flanked with loxP sites via homologous recombination in
embryonic stem cells. Therefore, the targeting vector pPNT-
FRT3-gskip was transfected into E14.1 mouse embryonic stem
cells, and clones harboring the expected mutation (clone H3)
were identified by Southern analysis. Germline chimeras were
generated by injection in blastocyst using standard procedures.
Heterozygous Gskip/ mice lacking exon 2 were obtained
upon mating to the general B6.C-Tg(CMV-cre)1Cgn/J Cre
deleter strain (28). Cre-mediated deletion results in the deletion
of a genomic region encoding 86 out of a total of 119 amino
acids of GSKIP including the start codon, thus causing a Gskip
null mutation (Gskip/). Gskip/ as well as Gskipflx/wt mice
were backcrossed to C57BL/6 animals for at least 10 genera-
tions. For genotyping, the following primers were used:
GSKIP-fw (see Fig. 1C, red), 5AAAAGTTTAAAAAGGTCT
GGAAAGC 3 in combination with either GSKIP-rev (see Fig.
1C, blue), 5 TAG TGT TGC TTT TAA GAC AGG GTT T 3,
or loxP-rev (see Fig. 1C, green), 5 TCT GCA AGA AAG GAG
TAA CAG ATT T 3.
Animal Husbandry—All mice were housed and maintained
in a specific pathogen-free environment in the animal facility of
theMax Delbrück Center forMolecularMedicine according to
the recommendations of the Federation of European Labora-
tory Animal Science Associations (FELASA), with chow and
water ad libitum in air-conditioned rooms at 22–23 °C with a
standard 12-h light/dark cycle.Mice were weaned 4weeks after
birth and ear-punched for numbering, and female and male
micewere separated.After genotyping, one or two femaleswere
placed in a cage with one male for standard breeding. All pro-
cedures were carried out in accordance with the ethical guide-
lines of the Landesamt für Gesundheit und Soziales (LaGeSo),
Berlin, Germany. Embryo analysis was conducted as approved
by License G 0361/13.
Embryo Analysis—Timed matings were set up by intercross-
ing Gskip/ animals for the generation of homozygous
Gskip/ embryos. Genotype ratios were calculated and com-
pared with expected Mendelian ratios to determine the time
point of death of Gskip/ mice. E18.5 animals were born
through Caesarean sectioning, and P0 animals were abdomi-
nally delivered. E18.5 andP0 embryoswereweighed, lungswere
carefully dissected, and their ability to float onPBSwas tested as
readout for air in the lung. Dissections for optical inspections
and staining procedures were carried out for determination of
gross morphological abnormalities.
Tissue Lysis and Western Blot Analysis—Organs and whole
embryos were ground to powder in liquid N2 and resuspended
in standard radioimmunoprecipitation assay buffer containing
protease and phosphatase inhibitors (Roche Diagnostics,
Mannheim, Germany). Homogenates were sonicated and cen-
trifuged, and total protein concentrations of supernatants were
determined using the Coomassie Plus Bradford protein assay
(Thermo Scientific). Proteins (10–25 g) were separated by
12% SDS-PAGE and blotted onto PVDF membranes. Mem-
branes were blocked 1 h at room temperature with 1% BSA in
TBS-T and then incubated overnight at 4 °C with primary
antibodies directed against: GSKIP (custom-made, used as de-
scribed previously (6)), cyclin D1 (Abcam), GSK3, pGSK3-
Ser(P)-9, -catenin, Axin1, and GAPDH (Cell Signaling Tech-
nology), and PKA-RII and PKA-C (BDBiosciences). The blots
were washed and incubated with HRP-conjugated secondary
antibodies (Jackson ImmunoResearch Laboratories/Dianova)
andWestern chemiluminescence HRP substrate (Merck Milli-
pore). Signals were visualized using anOdyssey imaging system
(LI-COR Biosciences). Signals were semi-quantitatively ana-
lyzed using the ImageJ 1.47v software (National Institutes of
Health). For the evaluation of GSK3 protein activity, the ratio
was calculated between the signal intensity measured for inac-
tive GSK3 phosphorylated at Ser-9 (inactive) to the signal for
total GSK3 (both active and inactive forms). The ratios were
normalized to wild type controls and determined as -fold
changes as compared with wild type.
Isolation of Total RNA and Real-time Reverse Transcrip-
tion-PCR—Total RNA was isolated from homogenized mouse
tissue using TRIzol (Sigma-Aldrich) and chloroform according
to the manufacturer’s protocol. RNA (100–1,000 ng) was
reverse-transcribed according to the SuperScript III first-
strand synthesis kit protocol (Invitrogen, Thermo Fisher Scien-
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tific). Duplex-real-time RT-PCRwas performed using the Taq-
Man system and a Bio-Rad iCycler and the comparative CT
method for relative gene expression analysis comparing wild
type and Gskip/ mouse tissue. GAPDH was included as a
control.
Hematoxylin-Eosin, Azan, and Whole-mount Alizarin Red/
Alcian Blue Stain—For histologic analysis, freshly dissected
embryos and isolated heads were rinsed briefly in PBS, fixed in
4% paraformaldehyde, and embedded in paraffin. H&E and
Azan stain were used on sections of paraffin-embedded whole
embryos or skulls for morphological inspection according to
standard protocols. In accordance with ethical guidelines, ani-
mals were sacrificed by decapitation; hence whole-body sec-
tions lack the skull. For microscopic evaluation, a digital
Keyence BZ-8100E bright-field microscope was used. For
whole-mount staining of skulls, E18.5 embryos were dissected
anddecapitated. The lower jawof the skull including the tongue
was carefully removed, and the remaining upper part of the
skull eviscerated and fixed in 99% ethanol at room temperature
for 2–5 days (in a total volume of 15 ml per skull). The material
was processed by a 24-h incubation in acetone at room temper-
ature for fat removal. Samples were rinsed once in distilled
water. Each skull was transferred to a new tube containingAliz-
arin red/Alcian blue double staining solution (0.3%Alcian blue,
0.1% Alizarin red) optimized according to Erdog˘an et al. (29).
Staining was performed at 40 °C for 4 days under rotation.
Skulls were briefly washed and transferred into 1.5% aqueous
KOH solution for 4 days for clearing. The skulls were trans-
ferred into an aqueous solution of 20% glycerol containing 1%
KOHuntil the skulls were clearly visible through the surround-
ing tissue. Cleared specimens were placed successively into 50,
80, and 100% glycerol for 3–5 days each for long-term storage
and imaging. Stained skulls were viewed under a stereomicro-
scope connected to a Leica DFC 495 camera.
Statistical Analysis—All values are presented asmeans S.E.
Data were analyzed with GraphPad Prism 5.01 software using
paired or unpaired Student’s t test (for comparison of two
groups) or one-way analysis of variance in combination with
Bonferroni’s multiple comparison post test (for comparison of
three ormore groups). For the statistical evaluation of distribu-
tions, the contingency test 2 was used. A p value  0.05 was
considered statistically significant.
Results
Generation of a Gskip KO Mouse—The human GSKIP gene
(also known as C14orf129 or HSPC120) encodes four alterna-
tively spliced transcripts (National Center for Biotechnology
Information (NCBI)). Splice variant 1 is the longest; the others
differ only in their 5-UTR as compared with transcript 1. Only
a single transcript is expressed from the mouse Gskip gene
(4933433P14Rik). For the generation of a conditional Gskip
knock-outmouse, theCre/loxP systemwas used (Fig. 1). Exon 2
of the Gskip gene contains the start codon and encodes the
PKA-binding domain and 86 of the total of 139 amino acids.
Exon 2 was flanked by loxP sites and thereby targeted for Cre-
mediated deletion (Fig. 1A). Recombinant ES cells were identi-
fied via Southern blotting (Fig. 1B). The successful deletion of
Gskip was confirmed at DNA (Fig. 1C), mRNA (Fig. 1D), and
protein levels (Fig. 1E) in tissues of newborn (P0) mice.
Hemizygosity ofGskipAffects RNAbutNot Protein Expression
Levels—GskipmRNA levels in adultGskip/micewere signif-
icantly down-regulated in heart, lung, liver, brain, pancreas,
kidney cortex, and spleen, with the strongest reduction appear-
ing in the lung (Fig. 2A). In contrast, of all the tissues that were
analyzed in Gskip/ mice, only the renal medulla exhibited
changes inGSKIP protein levels, where expressionwas reduced
(Fig. 2B). Hence, hemizygosity in Gskip/ animals does not
affect GSKIP protein levels in most tissues. In line with these
data, Gskip/mice did not exhibit any overt phenotype.
Gskip Deficiency Causes Perinatal Lethality—Timedmatings
between heterozygousGskip/ animals were set up to analyze
Gskip/ embryos at different developmental stages. The
expected Mendelian ratios of wild type to heterozygous to
homozygous knock-out mice of 1:2:1 were observed up to
embryonic day 16.5 (E16.5; Table 1). The number of the
Gskip/ embryos decreased significantly after E16.5. Al-
though many Gskip/ embryos were still alive at E18.5, the
embryos rapidly died within 5–30 min after Caesarean section,
whereas wild type and heterozygous controls survived (Table
1). At parturition (P0), no viable GSKIP/ embryos were
detectable. At P0, maternal cannibalism could not be excluded
and may have led to an underrepresentation of Gskip/
embryos. Therefore, parturition appears to be the critical time
point in the lethality ofGskip-deficientmice. The loss of GSKIP
causes perinatal lethality and is not compatible with life.
Gskip/ (n  43) and Gskip/ (n  42) E18.5 embryos
were genotyped for the presence of the Y chromosome-specific
gene Sry. Male (Sry-positive) and female embryos were present
in the tested groups in a similar distribution of 1:1. This indi-
cates that the Gskip/ phenotype in mice is sex-independent
(data not shown).
Gskip-deficientMice DoNot Initiate Breathing at Birth—The
cause of the perinatal lethality seemed to be acute respiratory
distress marked by cyanosis. All Gskip/ embryos at E18.5
appeared cyanotic and pale (Fig. 3A, upper). Visual inspection
of the organs of Gskip/ mice at E18.5 did not reveal aberra-
tions that could obviously explain the lung phenotype: e.g. the
diaphragm appeared normal, and gross histological abnormal-
ities did not appear in an analysis of Azan-stained E18.5 whole-
body sections in different planes (Fig. 3A, lower). In addition, no
significant changes in body weight were noticed between wild
type, heterozygous, and Gskip/ embryos at E18.5 or at P0
(Fig. 3B). E18.5Gskip/mice exhibited distinct gaspingmove-
ments and costal retraction, indicating a normal neuromuscu-
lar function and respiratory drive. However, a marked reduc-
tion in breathing frequency, usually in excess of 90%, was
observed as compared with wild type littermates. Despite
extensive efforts to breathe, all Gskip/ mice died within 30
min of delivery.
As residual air remains in the lung even after death, it causes
the tissue to float on a liquid PBS surface. This permits the
amount of air in the lung to be used as an indicator of the
efficiency of breathing prior to death. The lungs were dissected,
weighed, andmeasured for their ability to float on PBS (Fig. 3,C
and D). Only 4.2% out of 24 tested Gskip/ lungs floated on a
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PBS surface (Fig. 3D), pointing to lung atelectasis. These results
indicate that cyanosis resulted from a failure of lung inflation in
the Gskip/ mice, and most likely a consequent reduction of
oxygen diffusion into the blood. No significant alterations were
noticed in postmortem lung weight to body weight ratios at
E18.5, indicating that pulmonary hypo- or hyperplasia was
absent in Gskip/mice (Fig. 3C).
Gskip/MiceDisplay a SecondaryCleft Palate—In addition
to the lung phenotype, an anatomical abnormality of the sec-
ondary palate was consistently detected in all Gskip/ mice.
Histological examination of H&E-stained E16.5 and E18.5
mouse skull sections revealed a pronounced palatal cleft (Fig.
4A). InGskip/mice, the secondary palatal shelf formation is
disturbed in the upper jaw and the two lateral hard palatal
FIGURE 1. Generation of conditional Gskip knock-out mice. A, targeting strategy. Exon 2 of Gskip was targeted for loxP-mediated excision upon Cre
recombination. The 3 probe for Southern blot analysis is indicated as a purple bar. B, identification of recombinant ES cell clones. Genomic DNA from selected
ES cell clones was digested with EcoRI, and fragments were analyzed by Southern blotting using a 3 XhoI/BamHI probe. For clone H3, site-specific recombi-
nation of the target vector was detected as indicated by an 8.5-kb fragment, arising from an additional BamHI site integrated together with the targeted
mutation. The 8- and 10-kb bands of the DNAmarker are highlighted in red. C, PCR for the determination of genotypes. The combination of two PCRs allowed
for clear genotype assignment (GSKIP-fw, red; GSKIP-rev, blue; loxP-rev, green). DNA fragment sizes are indicated.D,GskipmRNAexpression in P0mouse tissue
relative to Gapdh mRNA expression. Signals obtained by RT-PCR analyses for Gskip/ were normalized to wild type (Gskip/); n  5. E, GSKIP protein
expression in P0Gskip/ andGskip/mice.Upper panel, densitometric analysis of GSKIP protein expression relative toGAPDH. Signals obtained forGskip/
were normalized to Gskip/; n 11. Lower panel, the indicated tissues from P0mice were lysed, and proteins were separated by 12% SDS-PAGE. GSKIP and,
as a loading control, GAPDHweredetected. RepresentativeWesternblots are shown. Error bars indicatemeanS.E.Datawere analyzedusingpairedStudent’s
t test. ***, p 0.001.
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shelves do not fuse, resulting in no separation between the nasal
and oral cavities. In wild type controls, the two lateral maxillary
palatal paired shelves were fused and the midline epithelial
seam disappeared at E16.5 and E18.5 (Fig. 4A). Palatal shelf
development takes place between E12.5 and E15.5 (30); in wild
type mice, the closure of the two lateral palatal bones is com-
pleted by E16.5, as confirmed by a histological analysis of wild
type control mice. Our results show that GSKIP is essential for
proper palatal shelf formation and suggest that the palatal cleft
defect observed in Gskip/ mice at least contributes to the
defect in breathing that causes lethality.
The open connection between the nasal and the oral cavities
compromises both resonant control and intraoral pressure,
making it impossible for themice to cry or suckle. This explains
why newborn Gskip/ mice did not emit sounds upon soft
pressure of their tail, in contrast to the wild type. In wild type
animals, an inability to suckle or vocalize ultimately leads to
death by starvation, but this is not relevant in Gskip/ mice
due to their early perinatal death, which occurs before initiation
of food intake.
On the molecular level, the developmental processes medi-
ating elevation, rotation, and fusion of the palatal shelves
involve Shh/Ihh, TGF, bone morphogenetic protein (BMP),
and Wnt signaling (30, 31). Palatal clefting has been linked to
disruptions of various genes that encode components of the
Wnt signaling pathway (31–34). Intriguingly, the observed pal-
atal shelf malformation inGskip/mice at least partially phe-
nocopies that observed in Gsk3, Lrp6 (15), Gpr177 (16),
Wnt5a- (17), and Wnt9b- (18) deficient mice. GSK3 is an
intrinsic regulator of palatal shelf elevation (35), and the inac-
tivation of GSK3 in the palatal epithelium of mice causes a
cleft palate phenotype (36) resembling that of the Gskip/
mice.
As increased Wnt and decreased Shh signaling inhibit
GSK3-dependent palatal bone ossification (37), we studied
this feature in theGskip/mice.We performed whole-mount
Alizarin red/Alcian blue staining of the upper skull with an
emphasis on the secondary palatal bone and cartilage struc-
tures surrounding the cleft area. The properties of the dyes
account for the characteristic color pattern seen in Fig. 4B for
Gskip/ specimen. Calcific deposition, such as that found in
bones, appears purple (stained by Alizarin red), whereas carti-
lage is stained in blue as a glycan-rich structure by the acidic dye
Alcian blue. In Gskip/ mice, the purple border along the
bones was less pronounced, indicating a delay in ossification as
compared with wild type animals (Fig. 4B). In addition, the
skulls ofGskip/ animals exhibited invagination-like elevated
cartilage structures along the lateral hard palate fusion line in
the anterior direction (white arrows); these were not apparent
FIGURE2.LossofonealleleofGSKIP reducesmRNAbutnotproteinabun-
dance. A, mRNA expression ofGskip relative toGapdh in adultmouse tissues.
Signals ofmRNA fromGskip/micewerenormalized towild type (Gskip/).
n  4. B, GSKIP protein expression in adult Gskip/ and heterozygous
Gskip/mice. Upper panel, densitometric analysis of GSKIP protein expres-
sion relative toGAPDH.Gskip/was normalized toGskip/. n 8 (n 3 for
testis). Lower panel, representative Western blots showing the GSKIP and
GAPDH expression in adult tissue lysates. Lysates were separated by 12%
SDS-PAGE. GAPDHwas used as a loading control. Error bars indicate mean
S.E. Datawere analyzed using Student’s t test. *, p 0.05; **, p 0.01; ***, p
0.001.
TABLE 1
Genotype analysis of embryos at different developmental stages
Genotype ratio distributions were calculated from offspring of Gskip/  Gskip/matings. Percentages were calculated for all three genotypes and compared with the
expected Mendelian ratio. Embryos from at least 10 litters were included for each embryonic stage. 2 test was used for the statistical comparison of absolute numbers of
the observed distributions with the expected Mendelian distribution. *, p 0.05; ***, p 0.001. #, died within a few min or found dead; ns: not significant.
Embryonic stage (E) Gskip/a Gskip/b Gskip/c Total embryo number 2 test (p)
% % %
E11.5 26 51 23 66 0.9114 ns
E12.5 32 42 26 118 0.4645 ns
E14.5 23 52 25 71 0.9170 ns
E16.5 28 45 27 73 0.8029 ns
E18.5 29 53 18# 425 0.0473*
P0 22 66 12# 99 0.0301*
P28–35 47 53 0 373 	0.0001***
aMendelian ratios expected: 25 (1).
bMendelian ratios expected: 50 (2).
cMendelian ratios expected: 25 (1).
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in wild type littermates. The major difference from the wild
type was the strikingly reduced amount of purple structures in
Gskip/ mice, indicative of impaired ossification within the
secondary palatal shelf fusion area. Collectively, these results
show that GSKIP plays a critical role in coordinating secondary
palate formation and ossification.
A visible inspection of rib cage movements did not reveal
differences that would point to a generalized bone defect in the
FIGURE 3. Phenotype analysis of Gskip/ embryos. A, upper panel, representative images of wild type (Gskip/) and knock-out (Gskip/) embryos at
embryonic stage E18.5. Scale bar, 1 cm. Lower panel, representative images sowing Azan-stainedwhole-body paraffin sections of E18.5 specimens. Scale bar, 1
mm. B, body weight comparison of Gskip/, Gskip/, and Gskip/ littermates at E18.5 (n 16 for each group; upper panel) and P0 (n 6 for each group;
lower panel). Error bars indicate mean S.E. Data were analyzed using one-way of variance. C, lung weight to body weight ratio. Wet lung weights and body
weights were determined at E18.5 (n 6 for each group), and ratios were calculated. Error bars indicate mean S.E. Data were analyzed using one-way of
variance. D, the ability of E18.5 and P0 lungs to float on PBS surfaces was tested, and the number of floating lungs was compared with the expected number
(100% of all tested lungs) for each genotype. n 24 for each group. Data were analyzed using Fisher’s exact test. ***, p 0.001. ns, not significant. df, degrees
of freedom.
FIGURE 4. Loss ofGskip causes a cleft palate and delayed ossification along the secondary palate fusion site in themouse upper jaw. A, representative
H&E-stained coronal sections of paraffin-embedded E16.5 and E18.5 wild type (Gskip/) and knock-out (Gskip/) skulls. Scale bar, 200 m. T, tongue; PS,
palatal bone shelves. B, whole-mount Alizarin red/Alcian blue staining of dissected, evisceratedmouse skulls at E18.5 comparingGskip/ andGskip/mice.
Representative images are shown. n 5.Upper panels, overview. Lower panels, magnification from region indicated by thewhite boxes. Black arrows, border of
palatal bones.White arrows, anterior lateral hard palate fusion line. p, posterior; a, anterior. Scale bar: 1 mm.
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Gskip/ mice. Therefore, bone mineralization and ossifica-
tion are most likely not compromised outside the upper jaw.
This is supported by the observation that body size and weight
are not affected in Gskip/mice.
Loss of Gskip Causes a Reduction of the Phosphorylation of
GSK3 at Ser-9—We next evaluated the molecular mecha-
nisms that might underlie the critical functions of GSKIP dur-
ing development that we had observed. We have previously
shown that the overexpression of GSKIP in cultured cells facil-
itates the PKA phosphorylation and thus inhibition of GSK3
at Ser-9 (6), suggesting a critical role for GSKIP in GSK3 sig-
naling.We therefore analyzed the Ser-9 phosphorylation status
of GSK3 at different stages of embryonic development (E10.5,
E11.5, E12.5, E13.5, E14.5) in Gskip/ mice and controls.
Remarkably, the Ser-9 phosphorylation of GSK3was reduced
by 50–70% in Gskip/mice as compared with wild type con-
trols (Fig. 5, A and B), indicating an increase in GSK3 activity
upon GSKIP depletion as compared with wild type controls.
The ratios of phosphorylated and inactive GSK3 to total (both
active and inactive) GSK3 were 0.58  0.11 at E10.5, 0.37 
0.02 at E11.5, 0.68  0.06 at E12.5, 0.38  0.19 at E13.5, and
0.60 0.08 at E14.5. The observations cannot be explained by
the loss of PKA subunits, as the expression of the catalytic or the
regulatory RII subunits of PKAwas unaltered in theGskip/
mice. GSKIP only binds RII but not RI subunits of PKA (6).
Ser-9 phosphorylation was also reduced at E18.5 (Fig. 5, C and
D). Of note, in contrast to earlier stages of development, the
E18.5 tissuesdisplayedareduction in the levelofnon-phosphor-
ylated GSK3 protein. Hence, the ratio of inactive, Ser(P)-9
GSK3 to total (both active and inactive) GSK3 was 1.00 
0.06 on average in organs from E18.5, indicating that at this
stage, the overall level of GSK3 activity is decreased. The
expression levels of the protein components of theWnt signal-
ing pathway, including -catenin, Axin1, as well as the Wnt
targeting gene cyclin D1, were unaltered upon depletion of
GSKIP (Fig. 5, C–F). In particular, the fact that -catenin levels
are unaltered is in line with the presence of GSK3 in the
mostly inactive form. If active, GSK3 would phosphorylate
-catenin, which would in turn lead to its degradation.
To analyze the influence of GSKIP in a homogenous primary
cell population, we turned toGskip/mouse embryonic fibro-
blasts, generated from E12.5 embryos. The results were analo-
gous to those obtained with mouse embryos at early stages
(E10.5, E11.5, E12.5, E13.5, E14.5); although Gskip depletion
reduced the phosphorylation of GSK3 at Ser-9 2.5-fold, it did
not influence the protein expression of PKA subunits or of
components of the Wnt signaling pathway (data not shown).
Collectively, our results demonstrate a critical role of GSKIP
in cleft palate formation and provide strong evidence for an
indispensable role of GSKIP for postnatal life. GSKIP mediates
its effects at least partially throughmodulation of the activity of
GSK3 during development.
Discussion
This work shows that the loss of the Gskip gene in mice
causes developmental defects leading to a cleft palate and peri-
natal lethality caused by respiratory distress. In humans, the
anatomical dysfunction caused by a secondary cleft palate is
known as velopharyngeal insufficiency and involves problems
with breathing, eating, hearing, and speech; treatment com-
prises speech therapy and surgery (38–40). Hemifacial micro-
somia (Goldenhar syndrome) is a human craniofacial abnor-
mality that mainly affects the ear, mandible, muscle, and facial
soft tissues and is in severe cases associated with tracheal
obstruction and inadequate breathing (41). A genome-wide
linkage study of affected families linked hemifacial microsomia
to a region of 
10.7 centimorgans on chromosome 14q32,
between microsatellite markers D14S987 (14:96128759–
96129066) and D14S65 (14:97155145–97155291) (42). The
GSKIP gene is located at 14:96363452–96387290 (NCBI),
which places it in between these two microsatellites. These
observations together with the results reported here indicate
that the GSKIP gene is essential for normal craniofacial devel-
opment.Adysfunction or loss of the genemay even cause hemi-
facial microsomia. In contrast, a duplication of the chromo-
somal region 14q32.13-q32.2, which encodes GSKIP and other
proteins, has been associated with myeloid malignancies (7),
emphasizing the important physiological function of the
protein.
Prior to this study, the role of the GSKIP protein within the
context of the whole organism was completely unknown. We
show here that GSKIP controls GSK3 activity in vivo. GSK3
is constitutively active, and its activity is regulated by a combi-
nation of phosphorylation and sequestration by GSK3-bind-
ing proteins (11). The loss of GSKIP reduces the phosphoryla-
tion of GSK3 at Ser-9 up to developmental stage E14.5.
Decreased Ser-9 phosphorylation increases the activity of
GSK3 (43). At the time point of death at E18.5/P0, GSK3
activity decreased again in the Gskip/ tissues as a result of
low Ser-9 phosphorylation and a decrease in the level of total
GSK3. Thus GSKIP modulates GSK3 activity and protein
expression level during embryonic development.
The Gskip/ phenotype resembles that of Gsk3/ mice
with regard to the features of cleft palate and incomplete palatal
bone ossification. The secondary palate of Gsk3/ mice is
incompletely closed, indicating that GSK3 is essential for nor-
mal mammalian craniofacial development (36). Palatal mesen-
chyme-specificGsk3 deficiency does not induce a palatal cleft
inmice, whereas a deficiency ofGsk3 in the palatal epithelium
causes palatal clefting due to the failure of palate elevation after
FIGURE 5. The loss of the GSKIP protein reduces the phosphorylation of GSK3 at Ser-9 at different embryonic stages but does not affect expression
levels of PKA subunits or components of theWnt signaling pathway.Western blot analyses of lysates fromwild type (Gskip/) and knock-out (Gskip/)
micewereperformed. Proteins (15g)were separatedby12%SDS-PAGE. The indicatedproteinsweredetected, andGAPDHwas includedas a loading control.
A, C, and E, lysates of whole embryos (A) or E18.5 tissues (C and E) were assayed for-catenin, pGSK3 Ser-9, GSK3, regulatory RII, and catalytic C subunits of
PKA,Axin1, cyclinD1, andGSKIPproteinexpression. Representativeblots are shown.B,D, and F, densitometric analysis of proteinexpression relative toGAPDH.
Gskip/was normalized toGskip/. n 6 (B andD); n 3 (F). n. d., not detectable. Error bars indicatemean S.E.. Datawere analyzed using paired Student’s
t test; *, p 0.05; **, p 0.01; ***, p 0.001.
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E14.5 (35). However, Gsk3 deletion has additional effects; it
also leads to hypertrophic cardiomyopathy secondary to car-
diomyoblast hyperproliferation, which is associated with the
increased expression and nuclear localization ofGATA4, cyclin
D1, and c-Myc, three regulators of proliferation (44).Gsk3/
embryos display ventricular septal defects. Cardiac patterning
defects (44) and severe hepatic necrosis (45) cause the condi-
tionalGsk3/mice to die at aroundE13.5.Gskip/mice die
later (E18.5/P0). They do not display obvious cardiac defects.
This difference from the Gsk3/ mice may be explained by
the expression level of GSKIP in the heart, which is lower than
in other tissues. Gskip/ mice struggle from respiratory dys-
function when born and do not manage to initiate breathing ex
utero. The expression of constitutively active GSK3 in
knock-in mice expressing an enzyme that cannot be phosphor-
ylated at Ser-9 has a different outcome than the loss of GSKIP.
These knock-in mice are not impaired in their development
and are viable, but exhibit hyperactive behavior (46); however,
craniofacial abnormalities have not been reported. Knock-in
mice with a postnatal overexpression of constitutively active
GSK3-S9A show impaired postnatal neuron maturation and
differentiation, resulting in reduced brain volume due to a
decrease in the size of the somatodendritic compartment (47).
Conditional Gsk3/mice are viable and fertile and are born
at expectedMendelian ratios (44). The differences between the
Gskip/ and Gsk3/ phenotypes are not surprising, given
that GSKIP is one scaffolding protein that influences the local-
ization of GSK3 and some of its protein-protein interactions;
GSK3 also interacts with Axin and AKAP220, and these func-
tions might be preserved or enhanced after the loss of GSKIP.
GSKIP is also a scaffold for PKA. In its basal state, the PKA
holoenzyme is composed of two regulatory (R) and two cata-
lytic (C) subunits. The binding of cAMP to the R subunits trig-
gers the activation of PKA and the release of its C subunits,
which then phosphorylate nearby substrates (1, 3, 5, 48, 49).
The loss of the catalytic C subunits (Prkacb) or of RII subunits
(Prkar2a and Prkar2b) of PKA does not affect viability and fer-
tility, whereas the deletion of the widely expressed catalytic C
(Prkaca) or regulatory RI (Prkar1a) subunits is embryonically
lethal. GSKIP binds PKA RII subunits (KD  5 nM) and RII
subunits (KD 43 nM) with a somewhat lower efficiency (6), so
a Gskip/ phenotype might be expected to resemble the
knock-out of Prkar2a and Prkar2b. However, the loss of Gskip
obviously has a far more pronounced effect, which results in
perinatal lethality. The loss of Gskip most likely displaces not
only RII subunits from their cognate location but also the cat-
alytic subunits of PKA, whichmay then have effects as strong as
the loss of the C subunits itself, i.e. embryonic lethality. The
only AKAP that has previously been implicated in craniofacial
development is AKAP95. The knock-out of the Akap8 gene,
which encodes Akap95, is not critical for palatogenesis in itself;
notably, however, a double knock-out of the genes encoding
AKAP95 and the ATP-dependent microtubule depolymerizing
protein fidgetin induced palatal clefting in mice (50). AKAP95
is a nuclear protein, suggesting that a specific localization of
PKA by an AKAP within the nucleus may not be required to
coordinate proper craniofacial development. In contrast, as
GSKIP is a cytosolic protein, the coordination of PKA signaling
by GSKIP in the cytosol may be involved in the coordination of
proper craniofacial development.
In summary, our newly developed knock-outmodel provides
the first insights into the functions ofGSKIP in vivo. Our results
demonstrate an unexpected role ofGSKIP in craniofacial devel-
opment and provide strong evidence that it plays a regulatory
role in controlling GSK3 activity throughout development
and thereby palatal shelf fusion and ossification.
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